検索
Entera Bio Ltd
ENTXウォッチリストに追加
2.990USD
+0.040+1.36%
終値 07-31 16:00（ET）15分遅れの株価
139.40M時価総額
損失額直近12ヶ月PER
詳細情報 Entera Bio Ltd 企業名
Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.
Entera Bio Ltdの企業情報
企業コードENTX
会社名Entera Bio Ltd
上場日Jun 28, 2018
最高経営責任者「CEO」Toledano (Miranda Jayne)
従業員数18
証券種類Ordinary Share
決算期末Jun 28
本社所在地Hadassah / Jerusalem Bio
都市JERUSALEM
証券取引所NASDAQ OMX - NASDAQ BASIC
国Israel
郵便番号9112002
電話番号97225327151
ウェブサイトhttps://enterabio.com/
企業コードENTX
上場日Jun 28, 2018
最高経営責任者「CEO」Toledano (Miranda Jayne)
Entera Bio Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Chief Executive Officer, Director
Chief Executive Officer, Director
847.13K
+49.64%
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Chairman of the Board
Independent Chairman of the Board
363.25K
+10.54%
Mr. Sean Ellis
Mr. Sean Ellis
Independent Director
Independent Director
188.09K
-0.00%
Ms. Haya Taitel
Ms. Haya Taitel
Independent Director
Independent Director
98.48K
--
Mr. Gerald M. (Jerry) Ostrov
Mr. Gerald M. (Jerry) Ostrov
Independent Director
Independent Director
75.66K
+37.96%
Mr. Yonatan Malca
Mr. Yonatan Malca
Independent Director
Independent Director
59.42K
-30.29%
Dr. Hillel Galitzer
Dr. Hillel Galitzer
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Roger J. Garceau, M.D.
Dr. Roger J. Garceau, M.D.
Director
Director
--
--
Dr. Arthur C. Santora
Dr. Arthur C. Santora
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Dana Yaacov-Garbeli
Ms. Dana Yaacov-Garbeli
Chief Financial Officer
Chief Financial Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Chief Executive Officer, Director
Chief Executive Officer, Director
847.13K
+49.64%
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Chairman of the Board
Independent Chairman of the Board
363.25K
+10.54%
Mr. Sean Ellis
Mr. Sean Ellis
Independent Director
Independent Director
188.09K
-0.00%
Ms. Haya Taitel
Ms. Haya Taitel
Independent Director
Independent Director
98.48K
--
Mr. Gerald M. (Jerry) Ostrov
Mr. Gerald M. (Jerry) Ostrov
Independent Director
Independent Director
75.66K
+37.96%
Mr. Yonatan Malca
Mr. Yonatan Malca
Independent Director
Independent Director
59.42K
-30.29%
よくある質問
Entera Bio Ltdの上位5名の株主は誰ですか？
Entera Bio Ltdの上位5名の株主は以下のとおりです。Ms. Miranda Jayne Toledano
Entera Bio Ltd（ENTX）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Entera Bio Ltdの株式を保有している機関は34社あり、保有株式の総市場価値は約9.31Mで、全体の17.10%を占めています。2025Q4と比較して、機関の持ち株は-4212.00増加しています。